XBIO Xenetic Biosciences, Inc. - Common Stock

NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗
$2,90
Fiyat · May 19, 2026
Temel veriler itibarıyla May 12, 2026

XBIO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat
$2.90
Piyasa Değeri
P/E (TTM)
-1.4
EPS (TTM)
$-1.58
Gelir (TTM)
$3M
Temettü Verimi
ROE
D/E Borç/Özsermaye
52 Haftlık Aralık
$2 – $14

XBIO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $3M
10-point trend, -0.8%
2016-12-31 2025-12-31
Hisse Başına Kâr $-1.58
5-point trend, -187.3%
2021-12-31 2025-12-31
Serbest Nakit Akışı
Marjlar

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması
P/E (TTM)
5-point trend, +94.1%
-1.4

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
5-point trend, +156.4%
19.0%
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
5-point trend, +156.4%
20.4%
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
5-point trend, +156.4%
46.8%

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))
5-point trend, -187.3%
$-1.58

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik
5 Yıllık trend
XBIO
Akran Ortalaması

XBIO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

SAT 6 analist
  • Güçlü Al 0 0,0%
  • Al 0 0,0%
  • Tut 3 50,0%
  • Sat 1 16,7%
  • Güçlü Sat 2 33,3%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz
-0.07%
Dönem EPS Gerçek EPS Tahmin Sürpriz
30 Haziran 2025 $-0.45 $-0.65 0.20%
31 Mart 2025 $-0.59 $-0.73 0.14%
31 Aralık 2024 $-0.68 $-0.20 -0.48%
30 Eylül 2024 $-0.28 $-0.14 -0.14%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
XBIO -1.4 19.0%
ACXP $6M -0.5 -180.3%
BIAF
GOVX $296.2K -37.1% -862.3% -645.9%
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%
BCAB -0.6
APVO $9M -0.1 -217.2%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 17
XBIO için Yıllık Gelir Tablosu verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +2976411.00 $3M $3M $3M $2M $1M $436.9K $17.1K $0 $8M $3M $0 $0
Cost of Revenue · · · · · · · · · · · $0
Gross Profit · · · · · · · · · · · $0
R&D Expense 12-point trend, -51.5% $3M $3M $3M $5M $3M $2M $5M $3M $4M $44M $3M $6M
SG&A Expense 12-point trend, -58.4% $3M $3M $4M $4M $4M $3M $5M $4M $7M $7M $6M $7M
Operating Expenses 9-point trend, -55.0% $6M $7M $7M $8M $7M $14M $13M $7M · · · $13M
Operating Income 12-point trend, +78.1% $-3M $-4M $-5M $-7M $-6M $-14M $-13M $-7M $-4M $-47M $-10M $-13M
Interest Expense 4-point trend, -61.4% · · · · · · · · $1.8K $729.6K $267.0K $4.7K
Interest Income · · · · · · · · · · · $19.0K
Other Non-op 12-point trend, +101.8% $5.7K $-5.7K $25.4K $-1.6K $1.1K $-492 $3.3K $-24.6K $-24.6K $-85.4K $-235.4K $-326.9K
Pretax Income · · · · · · · · · · · $-14M
Income Tax 12-point trend, +0.00 $0 $0 $0 $0 $0 $-3M $0 $0 $0 $0 $0 $0
Net Income 12-point trend, +81.3% $-3M $-4M $-4M $-7M $-6M $-11M $-13M $-7M $-4M $-54M $-13M $-14M
EPS (Basic) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
EPS (Diluted) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
Shares (Basic) 5-point trend, -83.4% 1,701,571 1,541,339 1,528,210 1,422,443 10,279,408 · · · · · · ·
Shares (Diluted) 5-point trend, -83.4% 1,701,571 1,541,339 1,528,210 1,422,443 10,279,408 · · · · · · ·
Bilanço 25
XBIO için Yıllık Bilanço verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +214.4% $8M $6M $9M $13M $18M $12M $10M $571.6K $6M $4M $132.2K $3M
Receivables 3-point trend, +0.00 · · · · · · · · $0 $3M $0 ·
Prepaid Expense 12-point trend, -18.5% $166.3K $422.0K $603.8K $556.1K $479.4K $842.0K $722.1K $555.9K $285.0K $1M $247.3K $204.0K
Current Assets 12-point trend, +189.8% $8M $7M $10M $14M $19M $12M $11M $1M $6M $8M $4M $3M
PP&E (Net) 9-point trend, -100.0% · · · $0 $0 $0 $757 $5.0K $27.8K $42.4K $62.0K $119.4K
PP&E (Gross) 9-point trend, -100.0% · · · $0 $50.2K $57.0K $57.0K $89.4K $358.3K $349.1K $332.3K $586.1K
Accum. Depreciation 9-point trend, -100.0% · · · $0 $50.2K $57.0K $56.3K $84.4K $330.5K $306.7K $270.2K $466.7K
Goodwill 7-point trend, -100.0% · · · · · $0 $9M $3M $3M $3M $3M $3M
Other Non-current Assets 12-point trend, +57.5% $313.9K $313.9K $1M $1M $1M $810.0K $1M $705.7K $724.7K $66.3K $129.3K $199.3K
Total Assets 12-point trend, -48.7% $8M $7M $11M $15M $20M $13M $22M $14M $19M $21M $17M $16M
Accounts Payable 12-point trend, -69.7% $258.1K $283.6K $240.8K $287.4K $362.5K $327.4K $931.1K $934.1K $786.8K $1M $2M $852.8K
Accrued Liabilities 12-point trend, -49.6% $709.9K $610.6K $568.8K $785.8K $1M $574.0K $464.0K $664.0K $1M $838.9K $1M $1M
Current Liabilities 12-point trend, -64.1% $968.0K $894.3K $809.6K $1M $1M $936.9K $1M $2M $2M $2M $7M $3M
Capital Leases 2-point trend, +27043.00 · · · · · $27.0K $0 · · · · ·
Deferred Tax 7-point trend, -99.1% · · · · · $27.0K $3M $3M $3M $3M $3M $3M
Other Non-current Liabilities 5-point trend, -100.0% · · · · · · · $0 $0 $19.9K $38.8K $56.4K
Total Liabilities 12-point trend, -83.4% $968.0K $894.3K $809.6K $1M $1M $964.0K $4M $5M $5M $5M $10M $6M
Common Stock 12-point trend, -98.5% $2.3K $1.5K $1.5K $1.5K $13.5K $8.8K $6.1K $811 $9.0K $8.7K $4.9K $150.0K
Paid-in Capital 12-point trend, +134.2% $212M $208M $208M $208M $206M $194M $188M $168M $165M $164M $100M $91M
Retained Earnings 12-point trend, -164.3% $-200M $-197M $-193M $-189M $-183M $-177M $-166M $-153M $-146M $-142M $-88M $-76M
Treasury Stock Flat — no change across 12 periods $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M $5M
AOCI 12-point trend, -55.9% $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $253.7K $575.7K
Stockholders' Equity 12-point trend, -29.4% $7M $6M $10M $14M $18M $12M $17M $10M $14M $16M $7M $10M
Liabilities + Equity 12-point trend, -48.7% $8M $7M $11M $15M $20M $13M $22M $14M $19M $21M $17M $16M
Shares Outstanding 12-point trend, -98.4% 2,291,056 1,542,139 1,540,684 1,516,659 13,439,612 8,745,207 6,065,441 783,865 8,717,541 4,585,800 4,585,800 139,297,282
Nakit Akışı 8
XBIO için Yıllık Nakit Akışı verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
D&A 5-point trend, -100.0% · · · $0 $0 $1.0K · · · · $56.1K $88.7K
Stock-based Comp 12-point trend, -95.7% $64.8K $171.8K $283.1K $511.5K $410.4K $468.9K $806.1K $1M $2M $2M $2M $2M
Operating Cash Flow 12-point trend, +82.0% $-2M $-3M $-4M $-5M $-5M $-4M $-6M $-6M $1M $-9M $-5M $-13M
CapEx 5-point trend, -100.0% · · · · · · · $0 $9.3K $16.8K $1.7K $57.7K
Investing Cash Flow 8-point trend, +100.0% · · $0 $-500.0K $0 $0 $2.0K $22.5K $-9.3K $-16.8K · ·
Stock Issued 8-point trend, -60.0% $4M $0 · $0 $11M $5M $0 · · · $0 $10M
Financing Cash Flow 9-point trend, -68.5% $4M $0 · $0 $11M $5M $16M $1M $0 $13M · ·
Taxes Paid · · · · · · · · · · · $0
Hisse Başına 1
XBIO için Yıllık Hisse Başına verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
EPS (TTM) 5-point trend, -187.3% $-1.58 $-2.57 $-2.71 $-4.61 $-0.55 · · · · · · ·
Büyüme Oranları 3
XBIO için Yıllık Büyüme Oranları verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -88.5% 19.0% -1.6% 48.8% 47.1% 165.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -74.5% 20.4% 29.1% 79.8% · · · · · · · · ·
Revenue CAGR 5Y 46.8% · · · · · · · · · · ·
Değerleme (TTM) 5
XBIO için Yıllık Değerleme (TTM) verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +2976411.00 $3M $3M $3M $2M $1M $436.9K $17.1K $0 $8M $3M $0 $0
Net Income TTM 12-point trend, +81.3% $-3M $-4M $-4M $-7M $-6M $-11M $-13M $-7M $-4M $-54M $-13M $-14M
P/E 5-point trend, +94.1% -1.4 -1.6 -1.3 -0.6 -23.5 · · · · · · ·
P / Tangible Book 6-point trend, -95.4% 0.7 1.0 0.5 3.2 9.4 14.6 · · · · · ·
Earnings Yield 5-point trend, -1609.2% -72.8% -64.4% -78.5% -161.8% -4.3% · · · · · · ·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu
2025-12-312024-12-312023-12-312022-12-312021-12-31
Gelir $3M$3M$3M$2M$1M
Net Gelir $-3M$-4M$-4M$-7M$-6M
Seyreltilmiş Hisse Başı Kâr $-1.58$-2.57$-2.71$-4.61$-0.55

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.